DENNIS LEONE: Open Payments
NPI 1235347535 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 30 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $280 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $141 |
| Janssen Pharmaceuticals, Inc | 3 | $104 |
| Neurocrine BioSciences, Inc. | 3 | $90 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 4 | $58 |
| Noven Therapeutics, LLC | 4 | $57 |
| Lundbeck LLC | 2 | $52 |
| Alkermes, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: Auvelity, INVEGA SUSTENNA, INGREZZA, Jornay PM, Qelbree, Xelstrym, REXULTI, ARISTADA.
Industry payments across FL — which companies pay providers there.
